Meet Members of our Johnson & Johnson Customer AI Products & Strategy Team

At the heart of J&J Innovative Medicine in North America, the commercially focused Customer AI Products & Strategy (CAPS) team is driving real business impact utilizing data sciences combined with human creativity. Our approach goes beyond traditional methods, we focus on developing a deep understanding of our customers and business to generate novel insights, new customer experiences, create differentiated AI products and help augment our employees to compete more effectively.

Our team sits at the intersection of strategy, analytics, and business transformation and our success hinges on the ability to effectively bring together people, process and technology while blending human ingenuity with AI. We are on the lookout for individuals who have the ability to connect seemingly unrelated dots, who can drive change and challenge the status-quo and are constantly seeking to learn and grow.

Our success lies within our team. We are committed to hiring and developing the best talent and empowering them to innovate and create a culture of continuous learning to ensure we deliver meaningful value for our customers. Meet the outstanding individuals that make this vision a reality below.

expand

Karlee Ruth
Manager, Advanced Analytics, Johnson & Johnson Innovative Medicine

AI Improves Access: Meet Data Scientist Karlee Ruth

Karlee Ruth is optimistic about the future of AI and its pivotal role in streamlining processes that enhance patient care and access. As a member of the Advanced Analytics team at Johnson & Johnson Innovative Medicine, Karlee works on cross-functional teams to leverage data and build models to better meet business needs. From early discovery to market access and patient education, her team supports the best science and most creative minds as they work to serve patients.

“There are endless possibilities with AI. I am always learning something new and being challenged to think creatively.”

Karlee’s experience in leveraging data and deriving insights to build models and optimize resources shows how AI is playing a major role in the way the company conducts business. As human and machine learning continue to grow, so do the opportunities stemming from this partnership.

“At Johnson & Johnson Innovative Medicine, we have an opportunity to differentiate ourselves in the industry and produce innovative medicines while also reducing barriers to access. Using AI, the possibilities to provide safe and effective treatments to patients who need them only increase”

For some, AI poses a risk and raises fear of the unknown. For Karlee, it is essential that people understand we live in a rapidly changing landscape and that AI can help increase efficiency, enhance customer experience and provide a competitive advantage as well as growth opportunities.

“It is important to lean into this technology and upskill where possible – most importantly for the patients we aim to serve.”

expand

Sarah Howe
Associate Director, Commercial AI Products & Strategy, Johnson & Johnson Innovative Medicine

Transforming Healthcare Through AI: Meet Data Scientist Sarah Howe

Sarah Howe plays a dynamic role on the AI products and strategy team that stretches across all five therapeutic areas at Johnson & Johnson Innovative Medicine, working to weave together the expertise of data scientists, engineers, UI developers, and business partners from marketing and sales. By weaving these pieces together, the AI products and strategy team is accelerating discoveries and driving real-world impact.

“We work on a variety of digital innovations, from omni-channel campaign optimization to building applications from the ground up and leveraging generative AI to improve customer interactions. Every brand has its own set of challenges and opportunities, which can require a great deal of creativity in how we design our solutions.”

Driven by a fascination with mathematics, Sarah found her calling in AI by exploring the statistical underpinnings of deep learning models and the potential to solve business problems related to optimization. Sarah is excited by the transformative potential of large language models in customer-facing tools and internal workflows and sees personalized communication as a key in healthcare.

“I think most people prefer personalized communication. It is the way we engage with all major brands today, so why not in healthcare, which is even more personal in many ways.”

Looking forward, Sarah envisions a future where AI is the foundation of the Johnson & Johnson Innovative Medicine customer experience, revolutionizing engagement with healthcare providers and patients and freeing up time for individuals to tackle more complex problems.

expand

Fernando Penaloza
Manager Machine Learning Data Eng Omni, Johnson & Johnson Innovative Medicine

Responsible Use of Data Benefits Patients: Meet Data Scientist Fernando Penaloza

Fernando Penaloza is a key member of the Johnson & Johnson Innovative Medicine Data Science team, working to build prescriptive models that not only forecast outcomes for the field, but also provide actionable insights to drive desired outcomes. AI supports Fernando and team as they leverage expansive data sets and address the biggest challenges of our time to accelerate how J&J Innovative Medicine discovers, diagnoses and treats disease.

 “Our focus is always on putting our patients first. These prescriptive models support our efforts to reach more patients and providers who might benefit from our development of new and innovative treatments and medications.”

 Fernando’s journey to a career in data science was rooted in his passion for supporting people and the potential for AI to solve real-world problems. The prospect of improving lives through healthcare technology advancements became a driving force in his career.

 “AI has numerous benefits in terms of supporting our goals of reaching patients where they are and providing optimal support in their treatment journeys. As we commit to developing this technology, we are equally committed to ensuring its responsible use.”